nadolol

nadolol

 [na-do´lol]

a beta-adrenergic blocking agent that affects both β₁- and β₂-receptors; administered orally as an antihypertensive agent and for treatment of angina pectoris.

nadolol

/na·do·lol/ (na-do´lol) a nonselective β used for the treatment of angina pectoris and hypertension.

nadolol

(nā-dō′lōl)

n.

A beta-blocker drug, C₁₇H₂₇NO₄, used to treat hypertension and angina pectoris.

nadolol

[nad′ənol]

a beta-adrenergic blocking agent.

indications It is prescribed for long-term management of angina pectoris, for hypertension, and for migraine prophylaxis.

contraindications Bronchial asthma, sinus bradycardia, greater than first-degree conduction block, cardiogenic shock, overt cardiac failure, or known hypersensitivity to this drug prohibits its use.

adverse effects Among the more serious adverse effects are bronchospasm, bradycardia, precipitation of heart failure, cardiac arrhythmia, masking of signs of hypoglycemia in diabetics, fatigue, and lethargy. GI disturbances, rashes, and other allergic reactions may also occur.

nadolol

A non-selective beta-blocker drug that acts on all beta-adrenergic receptor sites. A brand name is Corgard.

nadolol (nadō´lol),

n brand name: Corgard;
drug class: nonselective β-adrenergic blocker;
action: competitively blocks stimulation of β-adrenergic receptors within the heart; produces negative chronotropic and inotropic activity, slows conduction of AV node, decreases heart rate, which decreases oxygen consumption in myocardium; also decreases activity of the renin-aldosterone-angiotensin system;
uses: chronic stable angina pectoris, mild to moderate hypertension.

nadolol

an adrenergic blocking agent that affects both β₁- and β₂-receptors.